Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 294, Issue 5, 2008, Pages

  Begriche, Karima ^a   Lettéron, Philippe ^a   Abbey Toby, Adjé ^b   Vadrot, Nathalie ^a   Robin, Marie Anne ^a   Bado, André ^a   Pessayre, Dominique ^a   Fromenty, Bernard ^a,c  

^a INSERM   (France)

^b BEAUJON HOSPITAL   (France)

^c CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

Author keywords

Adiponectin; Fatty liver; Hyperlipidemia; Mitochondria; Nonalcoholic steatohepatitis

Indexed keywords

3 HYDROXYBUTYRIC ACID; ADIPONECTIN; CHOLESTEROL; LEPTIN; LIVER ENZYME; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 1; ACONITATE HYDRATASE; CARRIER PROTEIN; GLUTATHIONE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; BROWN ADIPOSE TISSUE; C57BL 6 MOUSE; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; DIET; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GENE EXPRESSION; GLUCOSE INTOLERANCE; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPID DIET; MALE; METABOLIC DISORDER; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; APOPTOSIS; BIOSYNTHESIS; BLOOD; BODY COMPOSITION; C57BL MOUSE; GENETICS; GLUCOSE TOLERANCE TEST; LIVER; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACONITATE HYDRATASE; ADIPOSITY; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BODY COMPOSITION; CARRIER PROTEINS; CHOLESTEROL; DIET; ENERGY INTAKE; GLUCOSE TOLERANCE TEST; GLUTATHIONE; LEPTIN; LIVER; MALE; METABOLIC DISEASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, OBESE; OBESITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 45549103125     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00379.2007     Document Type: Article

References (48)

1. Ahima RS, Flier JS. Leptin. Annu Rev Physiol 62: 413-437, 2006.
2. Anini Y, Brubaker PL. Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes 52: 252-259, 2003.
3. Bassilian S, Ahmed S, Lim SK, Boros LG, Mao CS, Lee WN. Loss of regulation of lipogenesis in the Zucker diabetic rat. II. Changes in stearate and oleate synthesis. Am J Physiol Endocrinol Metab 282: E507-E513, 2002.
4. Begriche K, Igoudjil A, Pessayre D, Fromenty B. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6: 1-28, 2006.
5. db affects body composition and leptin homeostasis in adult mice. Am J Physiol Regul Integr Comp Physiol 274: R985-R990, 1998.
6. Ding X, Saxena NK, Lin S, Gupta N, Anania FA. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice. Hepatology 43: 173-181, 2006.
7. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation and hematopoiesis. J Leukoc Biol 68: 437-446, 2000.
8. Farooqi IS, Keogh JM, Kamath S, Jones S, Gibson WT, Trussell R, Jebb SA, Lip GY, O'Rahilly S. Partial leptin deficiency and human adiposity. Nature 414: 34-35, 2001.
9. Farooqi IS, O'Rahilly S. Genetics of obesity in humans. Endocr Rev 27: 710-718, 2006.
10. Feingold KR, Grunfeld C. Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. J Clin Invest 80: 184-190, 1987.
11. Friedman JM, Halaas JL. Leptin and the regulation of body weight in mammals. Nature 395: 763-770, 1998.
12. Fromenty B, Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 67: 101-154, 1995.
13. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752-1761, 2004.
14. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48: 1270-1274, 1999.
15. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab 30: 13-19, 2004.
16. Hager J, Clement K, Francke S, Dina C, Raison J, Lahlou N, Rich N, Pelloux V, Basdevant A, Guy-Grand B, North M, Froguel P. A polymorphism in the 5′ untranslated region of the human ob gene is associated with low leptin levels. Int J Obes Relat Metab Disord 22: 200-205, 1998.
17. Heo YR, Claycombe K, Jones BH, Wright P, Truett GE, Zemel M, Banz W, Maher M, Moustaid-Moussa N. Effects of fatty (fa) allele and high-fat diet on adipose tissue leptin and lipid metabolism. Horm Metab Res 34: 686-690, 2002.
18. Hoffstedt J, Eriksson P, Mottagui-Tabar S, Arner P. A polymorphism in the leptin promoter region (-2548G/A) influences gene expression and adipose tissue secretion of leptin. Horm Metab Res 34: 355-359, 2002.
19. Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev 87: 1409-1439, 2007.
20. Igoudjil A, Abbey-Toby A, Begriche K, Grodet A, Chataigner K, Peytavin G, Maachi M, Colin M, Robin MA, Lettéron P, Feldmann G, Pessayre D, Fromenty B. High doses of stavudine induce fat wasting and mild liver damage without impairing mitochondrial respiration in mice. Antivir Ther 12: 389-400, 2007.
21. Kopelman PG. Obesity as a medical problem. Nature 404: 635-643, 2000.
22. Kosone T, Takagi H, Horiguchi N, Ariyama Y, Otsuka T, Sohara N, Kakizaki S, Sato K, Mori M. HGF ameliorates a high-fat diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol 293: G204-G210, 2007.
23. Lafontan M, Viguerie N. Role of adipokines in the control of energy metabolism: focus on adiponectin. Curr Opin Pharmacol 6: 580-585, 2006.
24. Le Stunff C, Le Bihan C, Schork NJ, Bougnères P. A common promoter variant of the leptin gene is associated with changes in the relationship between serum leptin and fat mass in obese girls. Diabetes 49: 2196-2200, 2000.
25. Lettéron P, Sutton A, Mansouri A, Fromenty B, Pessayre D. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. Hepatology 38: 133-140, 2003.
26. Maher MA, Banz WJ, Truett GE, Zemel MB. Dietary fat and sex modify heterozygote effects of the rat fatty (fa) allele. J Nutr 126: 2487-2493, 1996.
27. Mammès O, Betoulle D, Aubert R, Giraud V, Tuzet S, Petiet A, Colas-Linhart N, Fumeron F. Novel polymorphisms in the 5′ region of the LEP gene: association with leptin levels and response to low-calorie diet in human obesity. Diabetes 47: 487-489, 1998.
28. Marra F. Leptin and liver tissue repair: do rodent models provide the answers? J Hepatol 46: 12-18, 2007.
29. Merriman RB, Aouizerat BE, Kane JP, Malloy MJ, Bass NM. A leptin variant with phenotype and genotype associations with NAFLD (Abstract). Hepatology 40, Suppl 1: 585A, 2004.
30. Qi Y, Takahashi N, Hileman SM, Patel HR, Berg A, Pajvani UB, Scherer PE, Ahima RS. Adiponectin acts in the brain to decrease body weight. Nat Med 10: 524-529, 2004.
31. Rask E, Olsson T, Söderberg S, Johnson O, Seckl J, Holst JJ, Ahrén B. Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. Diabetes Care 24: 1640-1645, 2001.
32. Ravussin E, Pratley RE, Maffei M, Wang H, Friedman JM, Bennett PH, Bogardus C. Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nat Med 3: 238-240, 1997.
33. Robin MA, Demeilliers D, Sutton A, Paradis V, Maisonneuve C, Dubois S, Poirel O, Lettéron P, Pessayre D, Fromenty B. Alcohol increases TNF-α and decreases NF-κB to activate hepatic apoptosis in genetically obese mice. Hepatology 42: 1280-1290, 2005.
34. Robinson AM, Williamson DH. Physiological roles of ketone bodies as substrates and signals in mammalian tissues. Physiol Rev 60: 143-187, 1980.
35. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120: 1183-1192, 2001.
36. Scharrer E. Control of food intake by fatty acid oxidation and ketogenesis. Nutrition 15: 704-714, 1999.
37. Schwarz JM, Linfoot P, Dare D, Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets. Am J Clin Nutr 77: 43-50, 2003.
38. Soares AF, Guichardant M, Cozzone D, Bernoud-Hubac N, Bouzaïdi-Tiali N, Lagarde M, Géloën A. Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radic Biol Med 38: 882-889, 2005.
39. Spiegelman BM, Flier JS. Obesity and the regulation of energy balance. Cell 104: 531-543, 2001.
40. Stansbie D, Brownsey RW, Crettaz M, Denton RM. Acute effects in vivo of anti-insulin serum on rates of fatty acid synthesis and activities of acetyl-coenzyme A carboxylase and pyruvate dehydrogenase in liver and epididymal adipose tissue of fed rats. Biochem J 160: 413-416, 1976.
41. Steinberg GR, McAinch AJ, Chen MB, O'Brien PE, Dixon JB, Cameron-Smith D, Kemp BE. The suppressor of cytokine signaling 3 inhibits leptin activation of AMP-kinase in cultured skeletal muscle of obese humans. J Clin Endocrinol Metab 91: 3592-3597, 2006.
42. Triscari J, Nauss-Karol C, Levin BE, Sullivan AC. Changes in lipid metabolism in diet-induced obesity. Metabolism 34: 580-587, 1985.
43. Unger RH. Hyperleptinemia: protecting the heart from lipid overload. Hypertension 45: 1031-1034, 2005.
44. Valle A, Català-Niell A, Colom B, Garcia-Palmer FJ, Oliver J, Roca P. Sex-related differences in energy balance in response to caloric restriction. Am J Physiol Endocrinol Metab 289: E15-E22, 2005.
45. Veech RL. The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins Leukot Essent Fatty Acids 70: 309-319, 2004.
46. Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE, Meier JJ. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 57: 678-687, 2008.
47. Zhang J, Matheny MK, Tümer N, Mitchell MK, Scarpace PJ. Leptin antagonist reveals that the normalization of caloric intake and the thermic effect of food after high-fat feeding are leptin dependent. Am J Physiol Regul Integr Comp Physiol 292: R868-R874, 2007.
48. Zhang Y, Guo KY, Diaz PA, Heo M, Leibel RL. Determinants of leptin gene expression in fat depots of lean mice. Am J Physiol Regul Integr Comp Physiol 282: R226-R234, 2002.